Signal Transduction in B cell Activation

B 细胞激活中的信号转导

基本信息

  • 批准号:
    6509814
  • 负责人:
  • 金额:
    $ 38.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1984
  • 资助国家:
    美国
  • 起止时间:
    1984-12-01 至 2003-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A critical feature of the immune system is its ability to distinguish between self and nonself seemingly ignoring self antigens while responding to and eliminating potential pathogens. Failure of this discrimination can result in autoimmunity. While, auto-reactive antigen receptors are clearly encoded in the genome, cells expressing these receptors are silenced by a variety of mechanisms. In the B cell compartment this occurs by antigen induced editing of receptors to change specificity, deletion by apoptosis, anergy and CD5 dependent hyporesponsiveness In the latter two cases, cells remain viable and competent to bind antigen, but antigen receptor signaling is altered. The long-term objectives of the application are to elucidate the molecular mechanisms underlying the antigen hyporesponsiveness of anergic B cells and peritoneal CD5+ cells. Specific Aims are to elucidate the biochemical underpinning and biological functions of three specific mechanisms of signal modulation revealed by studies conducted during the last funding period. Two of these mechanisms, active in anergic B cells, involve (1) destabilization of the antigen receptor preventing normal transmission of signals from membrane immunoglobulin to Ig-alpha/Ig-beta dimers which function as the receptor's transmembrane transducer, and (2) activation of a negative feedback regulatory loop involving the inositol 5 phosphatase SHIP and the linker Downstream of kinase, Dok. A third mechanism, apparently operative only in peritoneal CD5+ cells, is an inhibitory loop involving Lck, CD5 and SHP-2 and targets BLNK (SLP-65). The proposed studies will be pursued using multiple lymphoma and animal models, but will rely principally on the newly described Ars/A 1 transgenic model of anergy and the VH 11 VK9 transgenic model of CD5+ B 1 cells. They will involve genetic manipulation and a variety of biochemical and biological assays of signal transduction and cellular responses. These studies may reveal drug discovery targets for autoimmunity and immunodeficiency.
描述(由申请人提供):免疫系统的一个关键特征是

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Increase in the intracellular free calcium concentration is not an obligatory early event in lipopeptide-induced B-cell activation.
细胞内游离钙浓度的增加并不是脂肽诱导的 B 细胞活化的必然早期事件。
  • DOI:
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Hauschildt,S;Luckhoff,A;Langhorne,J;Wiesmuller,KH;Jung,G;Bessler,W;Cambier,JC
  • 通讯作者:
    Cambier,JC
Transmembrane signaling in T lymphocyte dependent B lymphocyte activation.
T 淋巴细胞依赖性 B 淋巴细胞激活中的跨膜信号传导。
  • DOI:
  • 发表时间:
    1989
  • 期刊:
  • 影响因子:
    7.8
  • 作者:
    Cambier,JC
  • 通讯作者:
    Cambier,JC
Modeling of T cell contact-dependent B cell activation. IL-4 and antigen receptor ligation primes quiescent B cells to mobilize calcium in response to Ia cross-linking.
T 细胞接触依赖性 B 细胞激活的建模。
Structural compartmentalization of MHC class II signaling function.
MHC II 类信号传导功能的结构划分。
  • DOI:
    10.1016/0167-5699(93)90184-m
  • 发表时间:
    1993
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wade,WF;Davoust,J;Salamero,J;Andre,P;Watts,TH;Cambier,JC
  • 通讯作者:
    Cambier,JC
Alpha-chains of IgM and IgD antigen receptor complexes are differentially N-glycosylated MB-1-related molecules.
IgM 和 IgD 抗原受体复合物的 α 链是差异 N-糖基化的 MB-1 相关分子。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John C Cambier其他文献

Src-family kinases in B-cell development and signaling
B 细胞发育和信号转导中的 Src 家族激酶
  • DOI:
    10.1038/sj.onc.1208075
  • 发表时间:
    2004-10-18
  • 期刊:
  • 影响因子:
    7.300
  • 作者:
    Stephen B Gauld;John C Cambier
  • 通讯作者:
    John C Cambier

John C Cambier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John C Cambier', 18)}}的其他基金

Autoimmunity risk alleles compromising B cell anergy
损害 B 细胞无反应性的自身免疫风险等位基因
  • 批准号:
    9568080
  • 财政年份:
    2016
  • 资助金额:
    $ 38.03万
  • 项目类别:
Autoimmunity risk alleles compromising B cell anergy
损害 B 细胞无反应性的自身免疫风险等位基因
  • 批准号:
    9121221
  • 财政年份:
    2016
  • 资助金额:
    $ 38.03万
  • 项目类别:
Insulin Specific T and B cells in Type 1 Diabetes
1 型糖尿病中的胰岛素特异性 T 细胞和 B 细胞
  • 批准号:
    9180031
  • 财政年份:
    2016
  • 资助金额:
    $ 38.03万
  • 项目类别:
Perturbation of B cell anergy in T1D
T1D 中 B 细胞无反应性的扰动
  • 批准号:
    9225164
  • 财政年份:
    2016
  • 资助金额:
    $ 38.03万
  • 项目类别:
Perturbation of B cell anergy in T1D
T1D 中 B 细胞无反应性的扰动
  • 批准号:
    9121223
  • 财政年份:
    2016
  • 资助金额:
    $ 38.03万
  • 项目类别:
B Cells and Type 1 Diabetes
B 细胞和 1 型糖尿病
  • 批准号:
    8372067
  • 财政年份:
    2012
  • 资助金额:
    $ 38.03万
  • 项目类别:
B Cells and Type 1 Diabetes
B 细胞和 1 型糖尿病
  • 批准号:
    9104150
  • 财政年份:
    2012
  • 资助金额:
    $ 38.03万
  • 项目类别:
Mouse modeling of a human STING gene variant for infectious disease
人类 STING 基因变体感染性疾病的小鼠模型
  • 批准号:
    8282484
  • 财政年份:
    2012
  • 资助金额:
    $ 38.03万
  • 项目类别:
B Cells and Type 1 Diabetes
B 细胞和 1 型糖尿病
  • 批准号:
    8690052
  • 财政年份:
    2012
  • 资助金额:
    $ 38.03万
  • 项目类别:
Mouse modeling of a human STING gene variant for infectious disease
人类 STING 基因变体感染性疾病的小鼠模型
  • 批准号:
    8519291
  • 财政年份:
    2012
  • 资助金额:
    $ 38.03万
  • 项目类别:

相似海外基金

Modulation of T-/B-lymphocyte immigration affects subsequent allograft damage (B06)
T/B 淋巴细胞迁移的调节会影响随后的同种异体移植物损伤 (B06)
  • 批准号:
    517500221
  • 财政年份:
    2023
  • 资助金额:
    $ 38.03万
  • 项目类别:
    CRC/Transregios
development of therapeutic strategy for immune related adverse events by immune checkpoint inhivitor by focusing on B lymphocyte
以B淋巴细胞为重点,制定免疫检查点抑制剂免疫相关不良事件的治疗策略
  • 批准号:
    22K08541
  • 财政年份:
    2022
  • 资助金额:
    $ 38.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte Tumorigenesis
单羧酸转运蛋白1和4在EB病毒介导的B淋巴细胞肿瘤发生中的作用和调节
  • 批准号:
    10154328
  • 财政年份:
    2021
  • 资助金额:
    $ 38.03万
  • 项目类别:
Dissecting Hem-1 functions in B lymphocyte Development and Primary Immunodeficiency Disease
剖析 Hem-1 在 B 淋巴细胞发育和原发性免疫缺陷病中的功能
  • 批准号:
    10385848
  • 财政年份:
    2021
  • 资助金额:
    $ 38.03万
  • 项目类别:
The role of Semaphorin 4C-PlexinB2 interaction in B-lymphocyte differentiation
Semaphorin 4C-PlexinB2 相互作用在 B 淋巴细胞分化中的作用
  • 批准号:
    RGPIN-2017-06735
  • 财政年份:
    2021
  • 资助金额:
    $ 38.03万
  • 项目类别:
    Discovery Grants Program - Individual
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte Tumorigenesis
单羧酸转运蛋白1和4在EB病毒介导的B淋巴细胞肿瘤发生中的作用和调节
  • 批准号:
    10364632
  • 财政年份:
    2021
  • 资助金额:
    $ 38.03万
  • 项目类别:
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease
儿童镰状细胞病 B 淋巴细胞缺乏的特征
  • 批准号:
    10641800
  • 财政年份:
    2020
  • 资助金额:
    $ 38.03万
  • 项目类别:
Functional Consequences of Ubiquitin Depletion During B Lymphocyte Differentiation
B 淋巴细胞分化过程中泛素耗竭的功能后果
  • 批准号:
    10055003
  • 财政年份:
    2020
  • 资助金额:
    $ 38.03万
  • 项目类别:
Functional Consequences of Ubiquitin Depletion During B Lymphocyte Differentiation
B 淋巴细胞分化过程中泛素耗竭的功能后果
  • 批准号:
    10684125
  • 财政年份:
    2020
  • 资助金额:
    $ 38.03万
  • 项目类别:
How does aberrant B lymphocyte produce a origin of multiple myeloma cells?
异常B淋巴细胞如何产生多发性骨髓瘤细胞的起源?
  • 批准号:
    20K08738
  • 财政年份:
    2020
  • 资助金额:
    $ 38.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了